Mounjaro cost without insurance (2026)
Mounjaro is tirzepatide approved for type 2 diabetes. Its cash pricing sits in an odd place: about half of list through the manufacturer's own channel, and still meaningfully more than the identical molecule sold as Zepbound.
What Mounjaro costs, by route#
| Route | Price | Conditions | Source |
|---|---|---|---|
| LillyDirect self-pay | $499/mo | All dose strengths, flat. Not usable with active commercial insurance, Medicare, or Medicaid. | reported source |
| Mounjaro Savings Card | as low as $25/mo | Commercial insurance + a type 2 diabetes prescription required; terms and caps apply. | reported source |
| Retail list price | ~$1,023/mo | Before any program, coupon, or coverage. | reported source |
The same molecule, priced two ways#
Mounjaro and Zepbound are both tirzepatide from the same manufacturer. The label differs, the approved indication differs, and so does the self-pay program — Mounjaro is a flat $499 a month, while Zepbound is dose-tiered and starts lower:
| Zepbound dose | LillyDirect self-pay | vs Mounjaro flat $499 |
|---|---|---|
| 2.5 mg | $299 | $200/mo cheaper |
| 5 mg | $399 | $100/mo cheaper |
| 7.5 mg | $449 | $50/mo cheaper |
| 10 mg | $449 | $50/mo cheaper |
| 12.5 mg | $449 | $50/mo cheaper |
| 15 mg | $449 | $50/mo cheaper |
Zepbound rows from our tracked dataset, verified 2026-09-04. Maintenance pricing there requires refilling within 45 days.
If you're prescribed Mounjaro for type 2 diabetes#
- Commercial insurance? The savings card is the first stop — as low as $25 a month with a type 2 diabetes prescription, subject to its terms and caps.
- No coverage? LillyDirect self-pay at $499 flat beats retail by roughly half. It cannot be combined with active commercial, Medicare, or Medicaid coverage.
- On Medicare? The GLP-1 Bridge $50 copay covers weight-loss products, not Mounjaro for diabetes — your Part D coverage is the normal route. Our insurance guide has the questions to ask.
Common questions#
How much does Mounjaro cost without insurance?#
$499/mo through LillyDirect self-pay — All dose strengths, flat. Not usable with active commercial insurance, Medicare, or Medicaid. That is against a retail list price of about $1,023/mo before any program or coverage. Reported from published sources on 2026-09-06 and not yet checkout-verified by us; the manufacturer's own page is the final word.
Can I get Mounjaro for $25 a month?#
Only with commercial insurance and a type 2 diabetes prescription. The Mounjaro Savings Card is listed at as low as $25/mo, subject to its own terms and caps, and it cannot be used with Medicare or Medicaid. The self-pay route is a separate program and the two cannot be combined.
Is Zepbound cheaper than Mounjaro?#
Yes, and they are the same molecule — tirzepatide from the same manufacturer. Mounjaro is approved for type 2 diabetes and Zepbound for weight management, so which one applies to you is a clinical question, not a shopping one. On price: Mounjaro self-pay is $499/mo flat at every strength, while Zepbound self-pay is dose-tiered from $299 a month, verified 2026-09-04. If weight management is the indication, Zepbound is both the approved product and the cheaper one.
Prices reported from published sources on the date shown, not yet checkout-verified by us; the manufacturer's own page is the final word. Pricing journalism, not medical advice — indication and suitability are decisions for you and a licensed clinician. No link on this page earns us a commission; ordering is by cost, never compensation — disclosure.